Biotage AB
BIOT
ISIN SE0000454746 / Valor 3011313
Biotage AB
UMushroom community rating:
About company
Biotage AB is a global company based in Sweden that specializes in providing intelligent and sustainable workflow solutions for customers in various industries, including drug discovery, development, diagnostics, and analytical testing. With expertise in separations technology, Biotage aims to streamline customer workflows and enhance outcomes. The company, listed on NASDAQ Stockholm under the ticker symbol BIOT, operates globally with 700 employees serving over 80 countries.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (23.05.2024):
Q1 2024 Revenue Growth
Biotage AB reported a significant increase in revenue for the first quarter of 2024, with net sales rising to SEK 480 million, up 33% from SEK 361 million in the same quarter the previous year. Despite this overall increase, there was a slight organic decrease of 1.4%.
Q1 2024 EBITDA Improvement
For the first quarter of 2024, Biotage AB saw an improvement in EBITDA, which amounted to SEK 112 million compared to SEK 80 million in the first quarter of 2023. The EBITDA margin also increased to 23.4% from 22.3% in the previous year.
Q1 2024 Operating Performance
Biotage AB's operating profit for the first quarter of 2024 was SEK 67 million, up from SEK 54 million in the same quarter last year. However, the operating margin slightly decreased to 13.9% from 14.8%.
Q1 2024 Profit and Earnings Per Share
The company's profit after tax for the first quarter of 2024 was SEK 33 million, down from SEK 43 million in the corresponding quarter of the previous year. Earnings per share also decreased to SEK 0.42 from SEK 0.65.
Q1 2024 Cash Flow and Financial Position
Cash flow from operating activities for Biotage AB significantly increased in the first quarter of 2024 to SEK 108 million, up from SEK 11 million in the first quarter of 2023. The adjusted cash flow from operating activities was SEK 171 million, compared to SEK 68 million in the previous year. Net cash as of March 31, 2024, was SEK 426 million.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1093 M
Market cap (USD)
50,919
Daily traded volume (Shares)
151.1 / 146.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
